AbbVie shares hit record high as key immunology drug set for exclusivity until 2037 - Reuters

Reuters | Sept. 11, 2025, 3:17 p.m. | Original
AbbVie shares hit record high as key immunology drug set for exclusivity until 2037 Reuters
Southwest Airlines eyes long-haul flights in strategic overhaul - Reuters Oil prices slide 2% on worries about global oversupply, US demand - Reuters